Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARγ independent mechanisms

Background/Aims: Thiazolidinediones (TZD) are a new class of oral antidiabetic drugs that have been shown to inhibit growth of some epithelial cancer cells. Although TZD were found to be ligands for peroxisome proliferators activated receptor γ (PPARγ) the mechanism by which TZD exert their anticanc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Galli, A, Ceni, E, Crabb, D W, Mello, T, Salzano, R, Grappone, C, Milani, S, Surrenti, E, Surrenti, C, Casini, A
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2004 by Gut 2004
Assuntos:
Pancreas
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774261/
https://ncbi.nlm.nih.gov/pubmed/15479693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2003.031997
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados